← All organizations

Regend Therapeutics

Regend Therapeutics

For profitWebsite ↗

Also known as: Regend Therapeutics | Regend Therapeutics Co.Ltd | Regend Therapeutics XLotus (Jiangxi) Co, Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 31, 2026

Timeline

2010s

Jan 1, 2015
Regend Therapeutics— Founded

Drugs by trial phase (5 distinct, 16 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (22)

NCT07275788Lead sponsorPhase 1Jan 31, 2026
NCT07239895Lead sponsorEarly Phase 1Nov 30, 2025
NCT06081621Lead sponsorPhase 2Oct 20, 2023
NCT05638776CollaboratorPhase 2Jun 20, 2022
NCT05638776Lead sponsorPhase 2Jun 20, 2022
NCT05657184CollaboratorPhase 1/Phase 2May 14, 2021
NCT05657184Lead sponsorPhase 1/Phase 2May 14, 2021
NCT05594303CollaboratorPhase 1/Phase 2Nov 27, 2019
NCT03655795CollaboratorPhase 1Sep 30, 2018
NCT03655808CollaboratorPhase 1Sep 30, 2018
NCT03188627Lead sponsorPhase 1/Phase 2May 19, 2017
NCT03188627Reponsible party - principal investigatorPhase 1/Phase 2May 19, 2017
NCT03153800Lead sponsorEarly Phase 1Apr 5, 2017
NCT03156673CollaboratorEarly Phase 1Apr 1, 2017
NCT03092648CollaboratorPhase 1/Phase 2Mar 1, 2017

Details

Founded: Suzhou, CN Jan 1, 2015
Last known activity: Jan 31, 2026